This month's Nashville Medical News profiles the very promising cancer treatment technologies being tested and rolled out at various sites by Brentwood-based DiaTech Oncology. The company's main procedure appears to predict much more accurately than previous tests the effectiveness of drugs on cancerous cells.
“Patients are asking why this hasn’t been the standard of care, but the technology just wasn’t available until now,” Rogers said. “For decades we’ve been treating patients through trial and error because, unfortunately, we can’t pinpoint each patient’s individual biology based on past patients. We’ve been talking a lot about giving patients personalized cancer care, and instead of treating it by tissue of origin, we can now tell what each tumor is specifically sensitive to.”
- ALEX B FRUIN INHERITANCE TRUST; CANDACE F STEFANSIC INHERITANCE TRUST; CANDANCE F STEFANSIC INHERITANCE TRUST; FRUIN, ALEX B TRUSTEE; FRUIN ALEX B INHERITANCE TRUST; STEFANSIC, CANDACE F TRUSTEE; STEFANSIC CANDACE F INHERITANCE TRUST; STEFANSIC CANDANCE F INHERITANCE TRUST
- ROSS, BRIDGETT D
- COOKE, ETHEN LANYARD TRUSTEE; COOKE, ETHEN LEWIS ESTATE
- JACOBS, JESSICA ALEXANDRA; JACOBS, ERIKA BESS